<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the presence of <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (AA), therapeutic choices should be determined while taking into account not only changes for immediate improvement, but also both the risks for late-occurring complications and the following quality of life </plain></SENT>
<SENT sid="1" pm="."><plain>We report here data concerning a long-term clinical survey (5 to 18 years with a median of 12 years) including 156 nongrafted patients receiving <z:chebi fb="3" ids="50113">androgen</z:chebi> therapy; <z:hpo ids='HP_0000001'>all</z:hpo> patients were alive more than 5 years after diagnosis (40% of patients included at time of diagnosis in our multicentric analysis) </plain></SENT>
<SENT sid="2" pm="."><plain>Between the 5th and the 13th year follow-up, 21 patients died of various causes either related to AA or to its treatment: 12 of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> or <z:mp ids='MP_0001914'>hemorrhage</z:mp> secondary to <z:hpo ids='HP_0001876'>pancytopenia</z:hpo> (6 relapses and 6 that had never been improved; 2 with <z:hpo ids='HP_0004818'>paroxysmal nocturnal hemoglobinuria</z:hpo> [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e>]); 5 of <z:hpo ids='HP_0001909'>leukemia</z:hpo>; 1 of a non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>; 2 of late side effects following transfusion (1 acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome and 1 <z:hpo ids='HP_0011010'>chronic</z:hpo> B <z:hpo ids='HP_0012115'>hepatitis</z:hpo>); and a single case of <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> (the latter could possibly result of <z:chebi fb="3" ids="50113">androgen</z:chebi> therapy) </plain></SENT>
<SENT sid="3" pm="."><plain>Thirteen patients in total developed <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PNH</z:e> (among which 10 had clinical symptoms including 2 <z:hpo ids='HP_0011420'>deaths</z:hpo>, and 3 exhibited only biologic abnormalities) </plain></SENT>
<SENT sid="4" pm="."><plain>Few long-term side effects of <z:chebi fb="5" ids="50113">androgens</z:chebi> could be noticed </plain></SENT>
<SENT sid="5" pm="."><plain>Adult height was <z:mpath ids='MPATH_458'>normal</z:mpath> in patients treated during childhood and so was young women's fertility </plain></SENT>
<SENT sid="6" pm="."><plain>No <z:mp ids='MP_0003331'>malignant hepatoma</z:mp> occurred </plain></SENT>
<SENT sid="7" pm="."><plain>This survey allows the recording of late spontaneous hematologic improvement (between 5 and 10 years of evolution) </plain></SENT>
<SENT sid="8" pm="."><plain>This occurred in 50% of patients that had remained cytopenic 5 years after diagnosis </plain></SENT>
<SENT sid="9" pm="."><plain>Although bone marrow stem cell concentration remained abnormal after 10 years of evolution </plain></SENT>
<SENT sid="10" pm="."><plain>85% of patients had a <z:mpath ids='MPATH_458'>normal</z:mpath> red blood cell count, 80% a <z:mpath ids='MPATH_458'>normal</z:mpath> polymorphonuclear count, and 66% a <z:mpath ids='MPATH_458'>normal</z:mpath> platelet count </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients who did not show late complications had an excellent quality of life </plain></SENT>
</text></document>